News — Conferences/Events


American Drug Delivery & Formulation Summit

🇺🇲 We’ll be at the American Drug Delivery & Formulation Summit in Boston, 14–15 September. Callavid® is an intravaginal drug delivery platform, at clinical stage with progesterone delivery for threatened miscarriage and IVF support. A further development programme covers locally delivered antibiotics for UTI and AMR. Future applications include gynaecological cancers, menopause-related indications, HIV prophylaxis …

Merck Healthcare / M Ventures’ W Accelerate Innovation programme
Thang Vo-Ta
Co-founder & CEO

It really matters who is in the room you’re in. Two years ago Lara and I pitched at the inaugural Merck Healthcare / M Ventures W Accelerate Innovation programme run by W Group The event was fantastic. The seniority of the people in that room were impressive, and the conversations that started there became the …

University of Oxford SASHI 2026
Thang Vo-Ta
Co-founder & CEO

Day Two of the Oxford Summer Academy for the Social Science of Health Innovation (SASHI)– The Women’s Health Revolution: Women’s and Reproductive Health Equity –held at St Hilda’s College, University of Oxford 🏛️ Great to return to Oxford for a fireside chat with Dr Emma Thornton. I talked about exciting progress on our progesterone-Callavid® clinical …

Formulation & Delivery Europe 2026
Arturo Mendoza Meinhardt, PhD
Senior Scientist

It was great to attend Formulation & Delivery Europe 2026 in Basel last month – a valuable opportunity to explore the latest industry trends in drug formulation and delivery, connect with industry experts to build collaborations, and discuss the technologies shaping the future of healthcare. Innovation is moving quickly in combination products and alternative routes …

Co-hosting the ESHRE Sundowner

What a way to close out Day 2 of ESHRE 2026! 🌅 We were delighted to co-host an European Society of Human Reproduction and Embryology (ESHRE) Sundowner with our brilliant partners Hertility and Impli… held on the rooftop of the Lillet Bar overlooking the Thames and the iconic London skyline. 🚠 The energy was electric …

Chair of the WHH summit in Washington D.C.
Dr Lara Zibners
Co-founder & Chair

Super excited to chair the Women’s Health Horizons DC summit on October 7 and be a panelist on “Medical Education as Health Policy: If We Don’t Teach It, We Don’t Treat It.” Everything policy and women’s health. It’s a real milestone in my life. The realization that everyone would prefer it if what I have …

At ESHRE London 2026
Thang Vo-Ta
Co-founder & CEO

It’s been an intense but very productive 42nd European Society of Human Reproduction and Embryology (ESHRE) Congress – the world’s largest gathering of professionals in reproductive medicine and embryology, held at Excel London. 🌸 So many great conversations, catch-ups and new connections forged: all united by a shared mission to improve fertility outcomes in the …

INDEX 26 in Geneva

Our colleagues Ewa Radziwon and Shaun Knights had a very productive few days at INDEX Nonwovens INDEX™26 in #Geneva, hosted by EDANA, the voice of nonwovens 🇨🇭 As the world’s leading nonwovens exhibition, it was important for Calla Lily Clinical Care to attend again: reconnecting with existing suppliers, meeting potential new partners, and exploring exciting …

World Clinical Trials Day

It was recently World Clinical Trials Day, and our co-founder Lara took part in a special event hosted by SökerData and Covington & Burling LLP: 🔬 “Innovation in Action: Successful Women’s Clinical Trial Case Studies” 🧪 Lara shared the context, design and exciting early progress of our ongoing FREEDOM clinical trial evaluating Callavid® for threatened …

Returning to Barclays HQ for Demo Day
Thang Vo-Ta
Co-founder & CEO

About 18 months after taking part in the inaugural Barclays Demo Day, it was great to return to Barclays’ Canary Wharf HQ to present Calla Lily Clinical Care again. Last time, we were pitching our ambitious plans to transform drug delivery for women. This time, those plans are bolder than ever– but now backed by …